Procter & Gamble Hygiene and Health Care Limited Reports Rs 32,211 lakh Profit After Tax for H1 FY2026
Company posts Rs 19,584 lakh PAT in Q2 FY2026 with total revenue from operations at Rs 1,14,558 lakh for the quarter
Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a profit after tax of Rs 19,584 lakh for Q2 and Rs 32,211 lakh for H1 FY2026. The company’s revenue from operations reached Rs 1,14,558 lakh in Q2 and Rs 2,03,654 lakh in H1 FY2026. Total expenses for H1 stood at Rs 1,63,133 lakh, resulting in a pre-tax profit of Rs 43,165 lakh.
Procter & Gamble Hygiene and Health Care Limited
Financial Results
Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, recording a half-year profit after tax of Rs 32,211 lakh.
For the quarter ended September 30, 2026, the company reported revenue from operations of Rs 1,14,558 lakh and a profit after tax of Rs 19,584 lakh.
For the six months ended September 30, 2026, the company’s revenue from operations was Rs 2,03,654 lakh with total expenses amounting to Rs 1,63,133 lakh, resulting in a profit before tax of Rs 43,165 lakh and profit after tax of Rs 32,211 lakh.
The financial results, prepared in accordance with Indian Accounting Standard 34, were reviewed by the Audit Committee and approved by the Board of Directors with a limited review report from the statutory auditors.
The company operates in a single primary segment comprising manufacturing, trading, and marketing of health and hygiene products.
The statement of assets and liabilities as of September 30, 2026, shows total assets at Rs 2,12,938 lakh and total equity at Rs 88,409 lakh.
Highlights
- Quarterly revenue from operations stood at Rs 1,14,558 lakh for Q2 FY2026.
- Profit after tax for Q2 FY2026 was Rs 19,584 lakh.
- Half-year revenue from operations totaled Rs 2,03,654 lakh.
- Profit before tax for H1 FY2026 was Rs 43,165 lakh.
- Earnings per share for Q2 FY2026 were Rs 60.33 on a face value of Rs 10 per equity share.
- Financial results are unaudited but subject to limited review by statutory auditors.
Key Data Snapshot
What happened
- Procter & Gamble Hygiene and Health Care Limited released unaudited financial results for Q2 and H1 ending September 30, 2026.
- The results include the statement of assets and liabilities and the statement of cash flows.
- The Board of Directors approved the results on November 12, 2026.
Financial performance
- Revenue from operations for Q2 FY2026 was Rs 1,14,558 lakh and for H1 FY2026 was Rs 2,03,654 lakh.
- Profit before tax for H1 FY2026 was Rs 43,165 lakh, with a profit after tax of Rs 32,211 lakh.
- Earnings per share for Q2 FY2026 was Rs 60.33 on a face value of Rs 10 per share.
- The total expenses for H1 FY2026 were Rs 1,63,133 lakh.
Regulatory and governance context
- The financial results were prepared in alignment with Indian Accounting Standard 34 'Interim Financial Reporting'.
- These results were reviewed by the Audit Committee and subjected to a limited review by the company's statutory auditors.
- Results were submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) of India.
Background and context
- The company operates in manufacturing, trading, and marketing of health and hygiene products, including ointments, creams, cough drops, tablets, and feminine hygiene products.
- These operating segments are aggregated into a single primary reportable segment under Ind AS 108.
Highlights
- Quarterly revenue from operations stood at Rs 1,14,558 lakh for Q2 FY2026.
- Profit after tax for Q2 FY2026 was Rs 19,584 lakh.
- Half-year revenue from operations totaled Rs 2,03,654 lakh.
- Profit before tax for H1 FY2026 was Rs 43,165 lakh.
- Earnings per share for Q2 FY2026 were Rs 60.33 on a face value of Rs 10 per equity share.
- Financial results are unaudited but subject to limited review by statutory auditors.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 (Ind AS 34)
- Section 133 of the Companies Act, 2013
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Kaynes Technology India Limited Reports Q2 FY2027 Un-audited Results and Enters Joint Venture to Produce TFT Modules
Kaynes Technology India Limited released its un-audited financial results for the quarter and half year ended September 30, 2026, and approved a joint venture with Toyokawa Techno Private Limited to produce Thin-Film Transistor Display Modules in India, while proposing voluntary strike-off of a subsidiary.
Read Full StoryITI Limited Reports ₹49,528 Lakh Revenue and ₹6,368 Lakh Consolidated Loss Before Tax for Half Year Ending September 2026
ITI Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026, revealing total consolidated revenue of ₹49,528 lakh for the quarter and a consolidated loss before tax of ₹6,368 lakh for the half-year period.
Read Full StoryZetwerk Manufacturing Businesses Limited Reports Q2 FY2027 Loss with Rs. 886.06 Million Receivables Dispute, Appoints New Company Secretary
Zetwerk Manufacturing Businesses Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, reporting a loss before tax of Rs. 1,193.17 million for the quarter. The company highlighted ongoing litigation over receivables totaling Rs. 886.06 million, alongside key administrative updates.
Read Full Story